1-4 of 4
Valérie Dutoit
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2396: IMA950: A novel multi-peptide cancer vaccine for treatment of glioblastoma

Oliver Schoor, Norbert Hilf, Valérie Dutoit, Toni Weinschenk, Steffen Walter, Peter Lewandrowski, Sylvia Flohr, Claudia Trautwein, Cécile Gouttefangeas, Stefan Stevanović, Hans-Georg Rammensee, Philipp Beckhove, Christel Herold-Mende, Pierre-Yves Dietrich, Harpreet Singh
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2396.
https://doi.org/10.1158/1538-7445.AM10-2396
Published: 15 April 2010
View article titled, Abstract 2396: IMA950: A novel multi-peptide cancer vaccine for treatment of glioblastoma
Journal Articles

Heterogeneous T-Cell Response to MAGE-A10254–262: High Avidity-specific Cytolytic T Lymphocytes Show Superior Antitumor Activity

Valérie Dutoit, Verena Rubio-Godoy, Pierre-Yves Dietrich, Anne-Lise Quiqueres, Valérie Schnuriger, Donata Rimoldi, Danielle Liénard, Daniel Speiser, Philippe Guillaume, Pascal Batard, Jean-Charles Cerottini, Pedro Romero, Danila Valmori
Journal: Cancer Research
Cancer Res (2001) 61 (15): 5850–5856.
Published: 01 August 2001
View article titled, Heterogeneous T-Cell Response to MAGE-A10<sub>254–262</sub>: <subtitle>High Avidity-specific Cytolytic T Lymphocytes Show Superior Antitumor Activity</subtitle>
Open the PDF for Heterogeneous T-Cell Response to MAGE-A10<sub>254–262</sub>: <subtitle>High Avidity-specific Cytolytic T Lymphocytes Show Superior Antitumor Activity</subtitle> in another window
Journal Articles

Frequent Cytolytic T-Cell Responses to Peptide MAGE-A10254–262 in Melanoma

Danila Valmori, Valérie Dutoit, Verena Rubio-Godoy, Céline Chambaz, Danielle Liénard, Philippe Guillaume, Pedro Romero, Jean-Charles Cerottini, Donata Rimoldi
Journal: Cancer Research
Cancer Res (2001) 61 (2): 509–512.
Published: 01 January 2001
View article titled, Frequent Cytolytic T-Cell Responses to Peptide MAGE-A10<sub>254–262</sub> in Melanoma
Open the PDF for Frequent Cytolytic T-Cell Responses to Peptide MAGE-A10<sub>254–262</sub> in Melanoma in another window
Journal Articles

Naturally Occurring Human Lymphocyte Antigen-A2 Restricted CD8+ T-Cell Response to the Cancer Testis Antigen NY-ESO-1 in Melanoma Patients

Danila Valmori, Valérie Dutoit, Danielle Liénard, Donata Rimoldi, Mikaël J. Pittet, Patrick Champagne, Kim Ellefsen, Ugur Sahin, Daniel Speiser, Ferdy Lejeune, Jean-Charles Cerottini, Pedro Romero
Journal: Cancer Research
Cancer Res (2000) 60 (16): 4499–4506.
Published: 01 August 2000
View article titled, Naturally Occurring Human Lymphocyte Antigen-A2 Restricted CD8<sup>+</sup> T-Cell Response to the Cancer Testis Antigen NY-ESO-1 in Melanoma Patients
Open the PDF for Naturally Occurring Human Lymphocyte Antigen-A2 Restricted CD8<sup>+</sup> T-Cell Response to the Cancer Testis Antigen NY-ESO-1 in Melanoma Patients in another window